Kurt, Ender; Tolunay, Sahsine; Kanat, Ozkan; Manavoglu, Osman.J BUON; 21(3): 564-9, 2016 May-Jun.40.Circulating Tumor Cells in Breast Cancer Patients.Hall, Carolyn; Valad, Lily; Lucci, Anthony.Crit Rev Oncog; 21(1-2): 125-39, 2016.41.Prognostic value of microRNA-203a expression in breast cancer.Gomes, Bruno Costa; Martins, Manuela; Lopes, Paulina; Morujao, Ines; Oliveira, Mario; Araujo, Antonio; Rueff, Jose;Rodrigues, Antonio Sebastiao.Oncol Rep; 36(3): 1748-56, 2016 Sep.42.uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R.Huber, Michaela C; Mall, Rebecca; Braselmann, Herbert; Feuchtinger, Annette; Molatore, Sara; Lindner, Katrin; Walch, Axel; Gross, Eva; Schmitt, Manfred; Falkenberg, Natalie; Aubele, Michaela.BMC Cancer; 16: 615, 2016.43.The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?Sun, Yadong; Liu, Xiaofeng; Cui, Shude; Li, Lianfang; Tian, Peiqi; Liu, Shanqing; Li, Yong; Yin, Mengmeng; Zhang, Chongjian; Mao, Qixin; Wang, Jiaxiang.Tumour Biol; 37(7): 9555-63, 2016 Jul.44.Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer: A Cohort Study Emphasizing Equivocal Cases.Shao, Tiffany; Wood, Martha; Wing, Anthony; Hnatovska, Marta; Mendes, Maria; Brendan Mullen, J; Chang, Martin C.Am J Clin Pathol; 146(3): 339-45, 2016 Sep.45.p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.Guerra, Emanuela; Cimadamore, Alessia; Simeone, Pasquale; Vacca, Giovanna; Lattanzio, Rossano; Botti, Gerardo;Gatta, Valentina; D'Aurora, Marco; Simionati, Barbara; Piantelli, Mauro; Alberti, Saverio.BMC Cancer; 16: 649, 2016.46.Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets.Schindlbeck, C; Andergassen, U; Jueckstock, J; Rack, B; Janni, W; Jeschke, U.J Cancer Res Clin Oncol; 142(9): 1883-95, 2016 Sep.47.Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.Green, Andrew R; Soria, Daniele; Stephen, Jacqueline; Powe, Desmond G; Nolan, Christopher C; Kunkler, Ian; Thomas, Jeremy; Kerr, Gillian R; Jack, Wilma; Cameron, David; Piper, Tammy; Ball, Graham R; Garibaldi, Jonathan M; Rakha, Emad A; Bartlett, John Ms; Ellis, Ian O.J Pathol Clin Res; 2(1): 32-40, 2016 Jan.48.Prognostic significance of inflammatory factors expression by stroma from breast carcinomas.Fernandez-Garcia, Belen; Eiro, Noemi; Miranda, Maria-Angeles; Cid, Sandra; Gonzalez, Luis O; Dominguez, Francisco;Vizoso, Francisco J.Carcinogenesis; 37(8): 768-76, 2016 Aug.49.Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.Shiino, Sho; Kinoshita, Takayuki; Yoshida, Masayuki; Jimbo, Kenjiro; Asaga, Sota; Takayama, Shin; Tsuda, Hitoshi.Clin Breast Cancer; 16(4): e133-40, 2016 Aug.50.New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer.Hao, Shuang; He, Zhi-Xian; Yu, Ke-Da; Yang, Wen-Tao; Shao, Zhi-Min.Oncotarget; 7(17): 24824-31, 2016 Apr 26.51.PD-L1 expression in human cancers and its association with clinical outcomes.Wang, Xin; Teng, Feifei; Kong, Li; Yu, Jinming.Onco Targets Ther; 9: 5023-39, 2016.52.Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about "Triple-negative breast cancer: treatment challenges and solutions" by Collignon et al.Ieni, Antonio; Barresi, Valeria; Ricciardi, Giuseppina Rosaria Rita; Adamo, Barbara; Adamo, Vincenzo; Tuccari, Giovanni.Breast Cancer (Dove Med Press); 8: 157-9, 2016.53.West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by